Stock Earnings

Question 1

How did AVTX's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Avalo Therapeutics Inc is $-2.19, beating expectations of $-1.69.

Question 2

How did Avalo Therapeutics Inc AVTX's revenue perform in the last quarter?

Accepted Answer

Avalo Therapeutics Inc revenue for the last quarter is $-2.19

Question 3

What is the revenue estimate for Avalo Therapeutics Inc?

Accepted Answer

According to 10 of Wall street analyst, the revenue estimate of Avalo Therapeutics Inc range from $0.0 to $0.0

Question 4

What's the earning quality score for Avalo Therapeutics Inc?

Accepted Answer

Avalo Therapeutics Inc has a earning quality score of B+/53.22828. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Avalo Therapeutics Inc report earnings?

Accepted Answer

Avalo Therapeutics Inc next earnings report is expected in 2026-02-04

Question 6

What are Avalo Therapeutics Inc's expected earnings?

Accepted Answer

Avalo Therapeutics Inc expected earnings is $0.0, according to wall-street analysts.

Question 7

Did Avalo Therapeutics Inc beat earnings expectations?

Accepted Answer

Avalo Therapeutics Inc recent earnings of $0.0 does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-1.69	$-2.19	+29.58%	BEAT
Q2 '25	$-1.43	$-1.92	+34.26%	BEAT
Q1 '25	$-1.41	$-1.25	-11.34%	MISSED
Q4 '24	$-0.39	$-7.95	+1.93K%	BEAT
Q3 '24	$-1.21	$-1.25	+3.3%	BEAT

Avalo Therapeutics Inc (AVTX) Price

AVTX Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ